Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Albemarle (ALB) upgraded to Buy from Neutral at Goldman Sachs with analyst Robert Koort saying the selloff in companies tied to lithium is overdone. 2. Veon (VEON) upgraded to Overweight from Neutral at JPMorgan with analyst Alexei Gogolev stating that the company shed its Italian business at a "very attractive price". 3. Roku (ROKU) upgraded to Outperform from Perform at Oppenheimer with analyst Jason Helfstein saying the "rapid adoption" of The Roku Channel gives him incremental confidence in the channel's ability to garner viewership on other platforms. 4. Amedisys (AMED) upgraded to Buy from Neutral at BofA/Merrill with analyst Joanna Gajuk stating that last night's CMS proposal increased reimbursement visibility for the home health industry calling for a +2.1% rate update in 2019, the best update since 2007 following nine consecutive years of cuts. 5. NetEase (NTES) upgraded to Overweight from Underweight at JPMorgan with analyst Alex Yao saying he expects NetEase to end a six-quarter "earnings downgrade cycle" with its "lackluster" earnings growth starting to recover in Q2 and peaking in Q1 of 2019. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

"Game On" is The Fly's weekly recap of the stories powering up or beating down video game stocks. NEW RELEASES: This... To see the rest of the story go to thefly.com. See Story Here